The pivotal link between ACE2 deficiency and SARS-CoV-2 infection

Verdecchia, Paolo, Cavallini, Claudio, Spanevello, Antonio, Angeli, Fabio·2020·European Journal of Internal Medicine
DOI 10.1016/j.ejim.2020.04.037

Cited by (1,000)

Items 101–200 of 1,000

  1. Epigenetic underpinnings of inflammation: Connecting the dots between pulmonary diseases, lung cancer and COVID-19
    Shama Ahmad, Shajer Manzoor, Sazia Siddiqui, Nithya Mariappan, Iram Zafar, Aamir Ahmad, Aftab M. Ahmad · 2021 · Seminars in Cancer Biology
  2. Autoantibodies against ACE2 and angiotensin type-1 receptors increase severity of COVID-19
    Ana Isabel Rodriguez-Perez, Carmen M. Labandeira, María A. Pedrosa, Rita Valenzuela, Juan Antonio Suárez-Quintanilla, María Cortes-Ayaso, Plácido Mayán Conesa, José Luis Labandeira-García · 2021 · Journal of Autoimmunity
  3. Direct and indirect neurological, cognitive, and behavioral effects of COVID-19 on the healthy elderly, mild-cognitive-impairment, and Alzheimer’s disease populations
    Francesco Iodice, Valeria Cassano, Paolo Maria Rossini · 2021 · Neurological Sciences
  4. Point-of-care electrochemical testing of biomarkers involved in inflammatory and inflammatory-associated medical conditions
    Diana-Gabriela Macovei, Maria‐Bianca Irimeș, Oana Hosu, Cécilia Cristea, Mihaela Tertiş · 2022 · Analytical and Bioanalytical Chemistry
  5. Role of atmospheric particulate matter exposure in COVID-19 and other health risks in human: A review
    Chengyue Zhu, Kannan Maharajan, Kechun Liu, Yun Zhang · 2021 · Environmental Research
  6. Recent advances in SARS-CoV-2 Spike protein and RBD mutations comparison between new variants Alpha (B.1.1.7, United Kingdom), Beta (B.1.351, South Africa), Gamma (P.1, Brazil) and Delta (B.1.617.2, India)
    Paulo Ricardo da Silva Sanches, Ives Charlie‐Silva, Helyson Lucas Bezerra Braz, Cíntia Bittar, Marília Freitas Calmon, Paula Rahal, Eduardo Maffud Cilli · 2021 · Journal of Virus Eradication
  7. Development of child immunity in the context of COVID-19 pandemic
    Małgorzata Kloc, Rafik Mark Ghobrial, Ernest Piotr Kuchar, Sławomir Lewicki, Jacek Z. Kubiak · 2020 · Clinical Immunology
  8. Decoy ACE2-expressing extracellular vesicles that competitively bind SARS-CoV-2 as a possible COVID-19 therapy
    Jameel M. Inal · 2020 · Clinical Science
  9. COVID‐19 in Severe Asthma Network in Italy (SANI) patients: Clinical features, impact of comorbidities and treatments
    Enrico Marco Heffler, Aikaterini Detoraki, Marco Contoli, Alberto A. Papi, Giovanni Paoletti, Giacomo Malipiero, Luisa Brussino, Claudia Crimi, Daniela Morrone, Marianna Padovani et al. · 2020 · Allergy
  10. SARS-CoV-2 cell entry receptor ACE2 mediated endothelial dysfunction leads to vascular thrombosis in COVID-19 patients
    Ashutosh Kumar, Ravi Kant Narayan, Chiman Kumari, Muneeb A. Faiq, Maheswari Kulandhasamy, Kamla Kant, Vikas Pareek · 2020 · Medical Hypotheses
  11. The SARS-CoV-2 receptor, angiotensin-converting enzyme 2, is required for human endometrial stromal cell decidualization†
    Sangappa Basanna Chadchan, Pooja Popli, Vineet Kumar Maurya, Ramakrishna Kommagani · 2020 · Biology of Reproduction
  12. Vaccine formulations in clinical development for the prevention of severe acute respiratory syndrome coronavirus 2 infection
    Cole J. Batty, Mark T. Heise, Eric M. Bachelder, Kristy M. Ainslie · 2020 · Advanced Drug Delivery Reviews
  13. Upregulation of oxidative stress gene markers during SARS-COV-2 viral infection
    Narjes Saheb Sharif‐Askari, Fatemeh Saheb Sharif‐Askari, Bushra Mdkhana, Hawra Ali Hussain Alsayed, Habiba S. AlSafar, Zeyad Faoor Alrais, Qutayba A. Hamid, Rabih Halwani · 2021 · Free Radical Biology and Medicine
  14. The mechanism underlying extrapulmonary complications of the coronavirus disease 2019 and its therapeutic implication
    Qin Ning, Di Wu, Xiaojing Wang, Dong Xi, Tao Chen, Guang Chen, Hongwu Wang, Huiling Lü, Ming Wang, Lin Zhu et al. · 2022 · Signal Transduction and Targeted Therapy
  15. Long COVID: Association of Functional Autoantibodies against G-Protein-Coupled Receptors with an Impaired Retinal Microcirculation
    Charlotte Szewczykowski, Christian Yahya Mardin, Marianna Lucio, Gerd Wallukat, Jakob Hoffmanns, Thora Schröder, Franziska Raith, Lennart Rogge, Felix Heltmann, Michael Moritz et al. · 2022 · International Journal of Molecular Sciences
  16. Particulate matter (PM10) enhances RNA virus infection through modulation of innate immune responses
    Richa Mishra, Pandikannan Krishnamoorthy, S. Gangamma, Ashwin Ashok Raut, Himanshu Kumar · 2020 · Environmental Pollution
  17. Kawasaki-like diseases and thrombotic coagulopathy in COVID-19: delayed over-activation of the STING pathway?
    Jean‐Marie Berthelot, Ludovic O. Drouet, Frédéric Lioté · 2020 · Emerging Microbes & Infections
  18. Angiotensin-Converting Enzyme Gene Polymorphism and Severe Lung Injury in Patients with Coronavirus Disease 2019
    Haoyi Zheng, J. Jane Cao · 2020 · American Journal Of Pathology
  19. The role of mesenchymal stromal cells in immune modulation of COVID-19: focus on cytokine storm
    Maria Kavianpour, Mahshid Saleh, Javad Verdi · 2020 · Stem Cell Research & Therapy
  20. Implications of SARS‐CoV‐2 infection for neurogastroenterology
    Giovanni Marasco, Marco Vincenzo Lenti, Cesare Cremon, Maria Raffaella Barbaro, Vincenzo Stanghellini, Antonio Di Sabatino, Giovanni Barbara · 2021 · Neurogastroenterology & Motility
  21. Genetic susceptibility of COVID-19: a systematic review of current evidence
    SeyedAhmad SeyedAlinaghi, Mohammad Mehrtak, Mehrzad MohsseniPour, Pegah Mirzapour, Alireza Barzegary, Pedram Habibi, Banafsheh Moradmand Badie, Amir Masoud Afsahi, Amirali Karimi, Mohammad Heydari et al. · 2021 · European journal of medical research
  22. Intracranial hemorrhage in coronavirus disease 2019 (COVID-19) patients
    Isaac Cheruiyot, Prabjot K. Sehmi, Beryl Shitandi Ominde, Paul Bundi Karau, Musa Mislani, Brian Ngure, Beda Otieno Olabu, Julius Alexander Ogeng’o · 2020 · Neurological Sciences
  23. Approaches towards fighting the COVID‑19 pandemic (Review)
    Shih‐Chang Tsai, Chi‐Cheng Lu, DA-TIAN BAU, Yu‐Jen Chiu, Yu‐Ting Yen, Yuan‐Man Hsu, Chih‐Wei Fu, Sheng‐Chu Kuo, Yu‐Shiang Lo, Hong‐Yi Chiu et al. · 2020 · International Journal of Molecular Medicine
  24. COVID-19 endocrinopathy with hindsight from SARS
    Kothandaraman Narasimhan, Rengaraj Anantharaj, Bo Xue, Wen Shan Yew, S. Sendhil Velan, Neerja Karnani, Melvin Khee‐Shing Leow · 2020 · American Journal of Physiology-Endocrinology and Metabolism
  25. Evidence For and Against Direct Kidney Infection by SARS-CoV-2 in Patients with COVID-19
    Luise Hassler, Fabiola Reyes, Matthew A. Sparks, Paul A. Welling, DANIEL C. BATLLE · 2021 · Clinical Journal of the American Society of Nephrology
  26. ACE2 expression in rat brain: Implications for COVID-19 associated neurological manifestations
    Vito S. Hernández, Mario A. Zetter, Enrique C. Guerra, Ileana Hernández‐Araiza, Nikita Karuzin, Oscar R. Hernández‐Pérez, Lee E. Eiden, Limei Zhang · 2021 · Experimental Neurology
  27. COVID-19
    Paolo Verdecchia, Claudio Cavallini, Antonio Spanevello, Fabio Angeli · 2020 · Hypertension
  28. SARS-CoV-2 colonization of maternal and fetal cells of the human placenta promotes alteration of local renin-angiotensin system
    Sonam Verma, Chetanchandra S. Joshi, Rachel B. Silverstein, Mai He, Ebony Boyce Carter, Indira U. Mysorekar · 2021 · Med
  29. COVID-19 and Hypertension: The What, the Why, and the How
    Shah-Abas Muhamad, Azizah Ugusman, Jaya Kumar, Dominik S. Skiba, Adila A. Hamid, Amilia Aminuddin · 2021 · Frontiers in Physiology
  30. Retraction notice for: “Characteristics and risk factors for COVID-19 diagnosis and adverse outcomes in Mexico: an analysis of 89,756 laboratory-confirmed COVID-19 cases.” Theodoros V. Giannouchos, Roberto A. Sussman, José M. Mier, Konstantinos Poulas and Konstantinos Farsalinos. Eur Respir J 2020; in press.
    European Respiratory Society · 2020 · European Respiratory Journal · Retracted
  31. SARS-CoV-2/ACE2 Interaction Suppresses IRAK-M Expression and Promotes Pro-Inflammatory Cytokine Production in Macrophages
    Ioanna Pantazi, Ahmed Ali Al-Qahtani, Fatimah S. Alhamlan, Hani Alothaid, Sabine Matou‐Nasri, George Sourvinos, Eleni Vergadi, Christos Tsatsanis · 2021 · Frontiers in Immunology
  32. COVID-19 Mechanisms in the Human Body—What We Know So Far
    Ashutosh Kumar, Ravi Kant Narayan, Pranav Prasoon, Chiman Kumari, Gurjot Kaur, Santosh Kumar, Maheswari Kulandhasamy, Kishore Sesham, Vikas Pareek, Muneeb A. Faiq et al. · 2021 · Frontiers in Immunology
  33. Insights on SARS-CoV-2 Molecular Interactions With the Renin-Angiotensin System
    Larissa Braga Costa, Lucas Giandoni Perez, Vitória Andrade Palmeira, Thiago Macedo e Cordeiro, Victor Teatini Ribeiro, Katharina Lanza, Ana Cristina Simões e Silva · 2020 · Frontiers in Cell and Developmental Biology
  34. Potential Detrimental Role of Soluble ACE2 in Severe COVID-19 Comorbid Patients
    Mahmudur Rahman, Maruf Hasan, Asif Ahmed · 2020 · Reviews in Medical Virology
  35. Genetic and epigenetic factors associated with increased severity of Covid‐19
    Zafer Yildirim, Oyku Semahat Sahin, Seyhan Yazar, Vildan Bozok Çetintaş · 2021 · Cell Biology International
  36. Coronavirus Disease 2019 in Children
    Melissa Borrelli, Adele Corcione, Fabio Castellano, Francesca Fiori Nastro, Francesca Santamaria · 2021 · Frontiers in Pediatrics
  37. ACE deletion allele is associated with susceptibility to SARS-CoV-2 infection and mortality rate: An epidemiological study in the Asian population
    Abhijit Pati, Harishankar Mahto, Sunali Padhi, Aditya K. Panda · 2020 · Clinica Chimica Acta
  38. A narrative review on characterization of acute respiratory distress syndrome in COVID-19-infected lungs using artificial intelligence
    Jasjit S. Suri, Sushant Agarwal, Suneet Kr. Gupta, Anudeep Puvvula, Mainak Biswas, Luca Saba, Arindam Bit, Gopal Singh Tandel, Mohit Agarwal, Anubhav Patrick et al. · 2021 · Computers in Biology and Medicine
  39. Role of probiotics and prebiotics in mitigation of different diseases
    Sabeena Manzoor, Shoib Mohmad Wani, Sajad Ahmad Mir, Danish Rizwan · 2022 · Nutrition
  40. ACE2 (Angiotensin-Converting Enzyme 2) in Cardiopulmonary Diseases
    Ravindra Kumar Sharma, Bruce R. Stevens, Alexander G. Obukhov, Maria B. Grant, Gavin Y. Oudit, Qiuhong Li, Elaine M. Richards, Carl J. Pepine, Mohan K. Raizada · 2020 · Hypertension
  41. Biomarkers of endothelial dysfunction and outcomes in coronavirus disease 2019 (COVID-19) patients: A systematic review and meta-analysis
    Andrianto Andrianto, Makhyan Jibril Al Farabi, Ricardo Adrian Nugraha, Bagas Adhimurda Marsudi, Yusuf Azmi · 2021 · Microvascular Research
  42. Management of epigenomic networks entailed in coronavirus infections and COVID-19
    Ranim El Baba, Georges Herbein · 2020 · Clinical Epigenetics
  43. Elucidating the Neuropathologic Mechanisms of SARS-CoV-2 Infection
    Mar Pacheco‐Herrero, Luis Oskar Soto-Rojas, Charles R. Harrington, Yazmin Montserrat Flores-Martinez, Marcos M. Villegas-Rojas, Alfredo M. León-Aguilar, Paola A. Martínez-Gómez, B. Berenice Campa-Córdoba, Ricardo Apátiga-Pérez, Carolin N. Corniel-Taveras et al. · 2021 · Frontiers in Neurology
  44. Endothelial contribution to COVID-19: an update on mechanisms and therapeutic implications
    Zhangjing Ma, Yi Yang, Yü Huang, Kathy O. Lui · 2021 · Journal of Molecular and Cellular Cardiology
  45. Coagulopathy and thromboembolic events in patients with SARS-CoV-2 infection: pathogenesis and management strategies
    Alessandro Allegra, Vanessa Innao, Andrea Gaetano Allegra, Caterina Musolino · 2020 · Annals of Hematology
  46. A meta-analysis of the association between obesity and COVID-19
    Jiao Yang, Zhuo Ma, Yan-Chang Lei · 2020 · Epidemiology and Infection
  47. SARS-CoV-2 cell entry beyond the ACE2 receptor
    Shamila D. Alipoor, Mehdi Seyed Mirsaeidi · 2022 · Molecular Biology Reports
  48. Hyperoxia and modulation of pulmonary vascular and immune responses in COVID-19
    Dusan Hanidziar, Simon Christopher Robson · 2020 · American Journal of Physiology-Lung Cellular and Molecular Physiology
  49. Computational study of pomegranate peel extract polyphenols as potential inhibitors of SARS-CoV-2 virus internalization
    Relja V. Suručić, Biljana Tubić, Miloš P. Stojiljković, Dragan M. Djuric, Maja Travar, Milkica Grabež, Katarina Šavikin, Ranko Škrbić · 2020 · Molecular and Cellular Biochemistry
  50. Experimental data using candesartan and captopril indicate no double-edged sword effect in COVID-19
    María A. Pedrosa, Rita Valenzuela, Pablo Garrido‐Gil, Carmen M. Labandeira, Gemma Navarro, Rafael Franco, José Luis Labandeira-García, Ana Isabel Rodriguez-Perez · 2021 · Clinical Science
  51. Nicotine and the nicotinic cholinergic system in COVID‐19
    Yousef Tizabi, Bruk Getachew, Robert Copeland, Michael Aschner · 2020 · FEBS Journal
  52. Why COVID-19 Transmission Is More Efficient and Aggressive Than Viral Transmission in Previous Coronavirus Epidemics?
    Fatma Elrashdy, Elrashdy M Moustafa Mohamed Redwan, Vladimir Nikolaevich Uversky · 2020 · Biomolecules
  53. Severe Acute Respiratory Syndrome Coronavirus 2, COVID-19, and the Renin-Angiotensin System
    Matthew A. Sparks, Andrew Michael South, Andrew D. Badley, Carissa Marrie Baker-Smith, DANIEL C. BATLLE, Biykem Bozkurt, Roberto Cattaneo, Steven D. Crowley, Louis J. Dell’Italia, Andria L. Ford et al. · 2020 · Hypertension
  54. Immunoinflammatory, Thrombohaemostatic, and Cardiovascular Mechanisms in COVID-19
    Selin Gencer, Michael Lacy, Dorothee Atzler, Emiel P. C. van der Vorst, Yvonne Döring, Christian Weber · 2020 · Thrombosis and Haemostasis
  55. Advances in the development of therapeutic strategies against COVID-19 and perspectives in the drug design for emerging SARS-CoV-2 variants
    Jialing Yin, Chengcheng Li, Chunhong Ye, Zhihui Ruan, Yicong Liang, Yongkui Li, Jianguo Wu, Zhen Luo · 2022 · Computational and Structural Biotechnology Journal
  56. SARS-CoV-2, an Underestimated Pathogen of the Nervous System
    Shweta Jakhmola, Omkar Indari, Sayantani Chatterjee, Hem Chandra Jha · 2020 · SN Comprehensive Clinical Medicine
  57. Free SARS-CoV-2 Spike Protein S1 Particles May Play a Role in the Pathogenesis of COVID-19 Infection
    Andrey V. Letarov, Vladislav V. Babenko, Eugene E. Kulikov · 2020 · Biochemistry (Moscow)
  58. COVID-19’s toll on the elderly and those with diabetes mellitus – Is vitamin B12 deficiency an accomplice?
    Andrew Kien Han Wee · 2020 · Medical Hypotheses
  59. Selinexor, a novel selective inhibitor of nuclear export, reduces SARS-CoV-2 infection and protects the respiratory system in vivo
    Trinayan Kashyap, Jackelyn Murray, Christopher James Walker, Hua Chang, Sharon Tamir, Bing Hou, Sharon Shacham, Michael G. Kauffman, Ralph A. Tripp, Yosef Landesman · 2021 · Antiviral Research
  60. Mechanisms of COVID-19-induced kidney injury and current pharmacotherapies
    Wissam H. Faour, Ali Choaib, Elio Issa, Francesca El Choueiry, Khodor Shbaklo, Maryline Alhajj, Ramy Touma Sawaya, Zeina Harhous, Eman A. Alefishat, Moni Nader · 2021 · Inflammation Research
  61. Endocrine aspects of ACE2 regulation: RAAS, steroid hormones and SARS-CoV-2
    Morag J. Young, Colin D. Clyne, Karen E. Chapman · 2020 · Journal of Endocrinology
  62. Role of ACE2 in pregnancy and potential implications for COVID-19 susceptibility
    Nayara Azinheira Nobrega Cruz, Danielle Stoll, Dulce Elena Casarini, Mariane Bertagnolli · 2021 · Clinical Science
  63. The mechanism of multiple organ dysfunction syndrome in patients with COVID‐19
    Wenbin Zhao, Hanmeng Li, Jianghua Li, Bin Xu, Jian Xu · 2022 · Journal of Medical Virology
  64. Characteristics and risk factors for COVID-19 diagnosis and adverse outcomes in Mexico: an analysis of 89,756 laboratory–confirmed COVID-19 cases
    Theodoros V. Giannouchos, Roberto A. Sussman, José Manuel Mier Odriozola, Konstantinos A. Poulas, Konstantinos E. Farsalinos · 2020 · medRxiv
  65. Leveraging coronavirus binding to gangliosides for innovative vaccine and therapeutic strategies against COVID-19
    Jacques Fantini, Henri Chahinian, Nouara Yahi · 2020 · Biochemical and Biophysical Research Communications
  66. Involvement of cardiovascular system as the critical point in coronavirus disease 2019 (COVID-19) prognosis and recovery
    Charalampos Lazaridis, Nikolaos I. Vlachogiannis, Constantinos Bakogiannis, Ioakim Spyridopoulos, Kimon S. Stamatelopoulos, Ioannis Kanakakis, Vassilios Pericles Vassilikos, Konstantinos Stellos · 2020 · Hellenic Journal of Cardiology
  67. Current approaches for target-specific drug discovery using natural compounds against SARS-CoV-2 infection
    Prashant S. Khare, Utkarsha Sahu, Satish Chandra Pandey, Mukesh Samant · 2020 · Virus Research
  68. ACE2 in the renin–angiotensin system
    Thiago Verano‐Braga, Ana Luiza Valle Martins, Daisy Motta‐Santos, Maria José Campagnole‐Santos, Robson A.S. Santos · 2020 · Clinical Science
  69. Interplay of Opposing Effects of the WNT/β-Catenin Pathway and PPARγ and Implications for SARS-CoV2 Treatment
    Alexandre Vallée, Yves Lecarpentier, Jean-Noël Vallée · 2021 · Frontiers in Immunology
  70. Development and simulation of fully glycosylated molecular models of ACE2-Fc fusion proteins and their interaction with the SARS-CoV-2 spike protein binding domain
    Austen Bernardi, Yihan Huang, Bradley Harris, Yongao Xiong, Somen Nandi, Karen A. McDonald, Roland Faller · 2020 · PLoS ONE
  71. Endothelialitis plays a central role in the pathophysiology of severe COVID-19 and its cardiovascular complications
    Christiaan J. Vrints, Konstantin Alexander Krychtiuk, Emeline M. Van Craenenbroeck, Vincent F. M. Segers, Susanna Price, Hein Heidbüchel · 2020 · Acta cardiologica. Supplementum
  72. Emerging materials for the electrochemical detection of COVID-19
    Georgia Balkourani, Angeliki Brouzgou, Maria Archonti, Nikolaos I. Papandrianos, Shuqin Song, Panagiotis E. Tsiakaras · 2021 · Journal of Electroanalytical Chemistry
  73. A tricompartmental model of lung oxygenation disruption to explain pulmonary and systemic pathology in severe COVID-19
    Dennis McGonagle, Charlie Bridgewood, James F. Meaney · 2021 · The Lancet Respiratory Medicine
  74. Deleterious Effects of SARS-CoV-2 Infection on Human Pancreatic Cells
    Syairah Hanan Shaharuddin, Victoria Wang, Roberta de Souza Santos, Andrew R. Gross, Yizhou Wang, Harneet Jawanda, Yi Zhang, Wohaib Hasan, Gustavo Garcia, Vaithilingaraja Arumugaswami et al. · 2021 · Frontiers in Cellular and Infection Microbiology
  75. Nonmuscle myosin heavy chain IIA facilitates SARS-CoV-2 infection in human pulmonary cells
    Jian Chen, Jun Fan, Zhilu Chen, Miaomiao Zhang, Haoran Peng, Liu Jian, Longfei Ding, Mingbin Liu, Chen Zhao, Ping Zhao et al. · 2021 · Proceedings of the National Academy of Sciences
  76. SNPs of ACE1 (rs4343) and ACE2 (rs2285666) genes are linked to SARS-CoV-2 infection but not with the severity of disease
    Nahid Alimoradi, Moein Sharqi, Dena Firouzabadi, Mohammad Moein Sadeghi, Seyed Mohammad Iman Moezzi, Negar Firouzabadi · 2022 · Virology Journal
  77. SARS-CoV-2 evolved variants optimize binding to cellular glycocalyx
    Sang Hoon Kim, Fiona L. Kearns, Mia A. Rosenfeld, Lane William Votapka, Lorenzo Casalino, Micah Papanikolas, Rommie E. Amaro, Ronit Freeman · 2023 · Cell Reports Physical Science
  78. An Assessment on Impact of COVID-19 Infection in a Gender Specific Manner
    Himanshu Agrawal, Neeladrisingha Das, Sandip Nathani, Sarama Saha, Surendra Kumar Saini, Sham S. Kakar, Partha Roy · 2020 · Stem Cell Reviews and Reports
  79. To stress or not to stress: Brain-behavior-immune interaction may weaken or promote the immune response to SARS-CoV-2
    Eva M.J. Peters, Manfred Schedlowski, Carsten Watzl, Ulrike Gimsa · 2021 · Neurobiology of Stress
  80. The pivotal link between ACE2 deficiency and SARS-CoV-2 infection: One year later
    Fabio Angeli, Martina Zappa, Gianpaolo Reboldi, Monica Trapasso, Claudio Cavallini, Antonio Spanevello, Paolo Verdecchia · 2021 · European Journal of Internal Medicine
  81. Role of angiotensin-converting enzyme 2 and pericytes in cardiac complications of COVID-19 infection
    Fulton A. Robinson, Ryan P Mihealsick, Brant M. Wagener, Peter Hanna, Megan D. Poston, Igor R. Efimov, Kalyanam Shivkumar, Donald B. Hoover · 2020 · American Journal of Physiology-Heart and Circulatory Physiology
  82. Altered gut microbial metabolites could mediate the effects of risk factors in Covid‐19
    Jiezhong Chen, Sean Hall, Luis Vitetta · 2021 · Reviews in Medical Virology
  83. Nicotinic cholinergic system and COVID-19: In silico identification of interactions between α7 nicotinic acetylcholine receptor and the cryptic epitopes of SARS-Co-V and SARS-CoV-2 Spike glycoproteins
    George Lagoumintzis, Christos T. Chasapis, Nikolaos Alexandris, Demetrios Kouretas, Socrates J. Tzartos, Elias Eliopoulos, Konstantinos E. Farsalinos, Konstantinos A. Poulas · 2021 · Food and Chemical Toxicology
  84. Potential effects of COVID-19 on reproductive systems and fertility; assisted reproductive technology guidelines and considerations: a review
    WY Lee, Annie Lai Fong Mok, Jacqueline Pui Wah Chung · 2021 · Hong Kong Medical Journal
  85. A Machine-Generated View of the Role of Blood Glucose Levels in the Severity of COVID-19
    Emmanuelle Logette, Charlotte Lorin, Cyrille Favreau, Eugenia Oshurko, Jay S. Coggan, Francesco Casalegno, Mohameth François Sy, Caitlin Monney, Marine Bertschy, Émilie Delattre et al. · 2021 · Frontiers in Public Health
  86. Structural and functional insights into the spike protein mutations of emerging SARS-CoV-2 variants
    Deepali Gupta, Priyanka Sharma, Mandeep Singh, Mukesh Kumar, Abdul Samath Ethayathulla, Punit Kaur · 2021 · Cellular and Molecular Life Sciences
  87. Severe COVID-19 induces autoantibodies against angiotensin II that correlate with blood pressure dysregulation and disease severity
    Priscilla S. Briquez, Sherin Juliet Rouhani, Jovian Yu, Athalia Rachel Pyzer, Jonathan Trujillo, Haley L. Dugan, Christopher T. Stamper, Siriruk Changrob, Anne I. Sperling, Patrick C. Wilson et al. · 2022 · Science Advances
  88. Computational study of the therapeutic potentials of a new series of imidazole derivatives against SARS-CoV-2
    Titilayo Omolara Johnson, Abayomi Emmanuel Adegboyega, Opeyemi Iwaloye, Abiodun Omokehinde Eseola, Winfried Plass, Boluwatife Afolabi, Damilare Rotimi, Eman Ibrahim Ahmed, Ashraf Albrakati, Gaber El‐Saber Batiha et al. · 2021 · Journal of Pharmacological Sciences
  89. Thromboplasminflammation in COVID-19 Coagulopathy: Three Viewpoints for Diagnostic and Therapeutic Strategies
    Satoshi Gando, Takeshi Wada · 2021 · Frontiers in Immunology
  90. Development of targeted nanoparticles loaded with antiviral drugs for SARS-CoV-2 inhibition
    Vanna Sanna, Sandro Satta, Tzung K. Hsiai, Mario Sechi · 2022 · European Journal of Medicinal Chemistry
  91. Blocking of the High-Affinity Interaction-Synapse Between SARS-CoV-2 Spike and Human ACE2 Proteins Likely Requires Multiple High-Affinity Antibodies: An Immune Perspective
    Indu Khatri, Frank J. T. Staal, Jacques J. M. van Dongen · 2020 · Frontiers in Immunology
  92. Paracetamol-Induced Glutathione Consumption: Is There a Link With Severe COVID-19 Illness?
    Piero Sestili, Carmela Fimognari · 2020 · Frontiers in Pharmacology
  93. SOCS, Intrinsic Virulence Factors, and Treatment of COVID-19
    Howard M. Johnson, Alfred S. Lewin, Chulbul M. I. Ahmed · 2020 · Frontiers in Immunology
  94. Medium-Term Outcomes in Severely to Critically Ill Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection
    Nandan Gautam, Shyam C. Madathil, Natascia Tahani, Shaun Bolton, Dhruv Parekh, James A. Stockley, Shraddha Goyal, Hannah Qureshi, Sadhika Yasmin, Brendan G. Cooper et al. · 2021 · Clinical Infectious Diseases
  95. Characterization of COVID-19-associated cardiac injury: evidence for a multifactorial disease in an autopsy cohort
    Paul Hanson, Felicia Liu-Fei, Coco Ng, Taylor A. Minato, Chi Peng Timothy Lai, Al Rohet Hossain, Rebecca Chan, Bobby Grewal, Gurpreet Kaur Singhera, Harpreet Rai et al. · 2022 · Laboratory Investigation
  96. Pathogenesis‐directed therapy of 2019 novel coronavirus disease
    Charles W. Stratton, Yi‐Wei Tang, Hongzhou Lu · 2020 · Journal of Medical Virology
  97. Paper-based immunoassay based on 96-well wax-printed paper plate combined with magnetic beads and colorimetric smartphone-assisted measure for reliable detection of SARS-CoV-2 in saliva
    Laura Fabiani, Vincenzo Mazzaracchio, Danila Moscone, Silvia Fillo, Riccardo De Santis, Anella Monte, Donatella Amatore, Florigio Romano Lista, Fabiana Arduini · 2021 · Biosensors and Bioelectronics
  98. Acute respiratory distress syndrome (ARDS) caused by the novel coronavirus disease (COVID-19): a practical comprehensive literature review
    Francisco Montenegro, Luis Unigarro, Gustavo Paredes, Tatiana Moya, Ana Romero, Liliana Torres, Juan Carlos López, Fernando Esteban Jara González, Gustavo Pozo, Andrés López‐Cortés et al. · 2020 · Expert Review of Respiratory Medicine
  99. The SARS-CoV-2 host cell receptor ACE2 correlates positively with immunotherapy response and is a potential protective factor for cancer progression
    Zhilan Zhang, Lin Li, Mengyuan Li, Xiaosheng Wang · 2020 · Computational and Structural Biotechnology Journal
  100. COVID-19 associated thrombotic thrombocytopenic purpura (TTP) ; A case series and mini-review
    Hamed Azhdari Tehrani, Maryam Darnahal, Mohammad Vaezi, Shirin Haghighi · 2021 · International Immunopharmacology